Marine Omega-3 Fatty Acids and Cardiovascular Disease

[1]  D. Mozaffarian,et al.  Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. , 2020, JAMA.

[2]  C. Lavie,et al.  Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials. , 2020, Mayo Clinic proceedings.

[3]  J. Manson,et al.  Marine Omega‐3 Supplementation and Cardiovascular Disease: An Updated Meta‐Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants , 2019, Journal of the American Heart Association.

[4]  J. Manson,et al.  Marine n‐3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer , 2019, The New England journal of medicine.

[5]  Deepak L. Bhatt,et al.  Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia , 2019, The New England journal of medicine.

[6]  F. Song,et al.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. , 2018, The Cochrane database of systematic reviews.

[7]  J. Mehta,et al.  Fish, Fish Oils and Cardioprotection: Promise or Fish Tale? , 2018, International journal of molecular sciences.

[8]  R. Collins,et al.  Effects of n‐3 Fatty Acid Supplements in Diabetes Mellitus , 2018, The New England journal of medicine.

[9]  M. Elisaf,et al.  Does Supplementation with Omega-3 PUFAs Add to the Prevention of Cardiovascular Disease? , 2017, Current Cardiology Reports.

[10]  J. Geleijnse,et al.  n-3 fatty acids and cardiovascular events after myocardial infarction. , 2010, The New England journal of medicine.

[11]  L. Alfredsson,et al.  Dietary Fish and Fish Oil and the Risk of Rheumatoid Arthritis , 2009, Epidemiology.

[12]  P. Calder.  Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. , 2008, Molecular nutrition & food research.

[13]  J. O’Keefe,et al.  Omega-3 fatty acids for cardioprotection. , 2008, Mayo Clinic proceedings.

[14]  W. Harris,et al.  Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives. , 2008, Atherosclerosis.

[15]  Y. Matsuzawa,et al.  Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis , 2007, The Lancet.

[16]  J. Lake,et al.  Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. , 2006, The Journal of clinical psychiatry.

[17]  Rhoda Au,et al.  Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. , 2006, Archives of neurology.

[18]  Dariush Mozaffarian,et al.  Fish intake, contaminants, and human health: evaluating the risks and the benefits. , 2006, JAMA.

[19]  Jennifer G. Robinson,et al.  Antiatherosclerotic and antithrombotic effects of omega-3 fatty acids. , 2006, The American journal of cardiology.

[20]  J. Reiffel,et al.  Antiarrhythmic effects of omega-3 fatty acids. , 2006, The American journal of cardiology.

[21]  Judith Wylie-Rosett,et al.  Diet and Lifestyle Recommendations Revision 2006: A Scientific Statement From the American Heart Association Nutrition Committee , 2006, Circulation.

[22]  Ethan M Balk,et al.  n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. , 2006, The American journal of clinical nutrition.

[23]  W. Mojica,et al.  The Efficacy of Omega–3 Fatty Acids on Cognitive Function in Aging and Dementia: A Systematic Review , 2006, Dementia and Geriatric Cognitive Disorders.

[24]  W. Harris.  Alpha-linolenic acid: a gift from the land? , 2005, Circulation.

[25]  A. Dyer,et al.  Fish Consumption and Incidence of Stroke: A Meta-Analysis of Cohort Studies , 2004, Stroke.

[26]  A. Dyer,et al.  Accumulated Evidence on Fish Consumption and Coronary Heart Disease Mortality: A Meta-Analysis of Cohort Studies , 2004, Circulation.

[27]  GISSI-Prevenzione Investigators,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial , 1999, The Lancet.

[28]  Roberto Marchioli,et al.  Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. , 1999 .

[29]  J. Kremer.  n-3 fatty acid supplements in rheumatoid arthritis. , 2000, The American journal of clinical nutrition.